Forte Biotech

Forte Biotech

Private
Singapore, Central SingaporeHealthcare & Life Scienceshttps://www.fortebio.tech/

Last Round

Grant

Dec 8, 2023

Total Funding Raised

$150,000

Company Overview

Forte Biotech is a Singapore- and Vietnam-based biotechnology company founded in 2021 that provides diagnostic solutions for the aquaculture industry. As a spin-off from the National University of Singapore, the company developed the RAPID (Really Accurate Prawn Infection Detector) platform, a point-of-care molecular testing system for farmers. This system uses LAMP PCR technology to enable the rapid, on-site detection of diseases in prawns and shrimp, such as White Spot Syndrome Virus (WSSV). The technology is designed to be user-friendly and provide lab-grade results in about an hour without extensive training or equipment, helping farmers prevent significant losses by taking early mitigative action. After a commercial launch in 2024, the company has supported farms across seven Asian countries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Environmental Monitoring

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

aquaculture diagnosticson-site diagnosticsshrimp disease detectionmolecular diagnosticsrapid diagnosticsLAMP PCRAquaTechpathogen detectionon-farm diagnosticsportable test kitaquaculture biosecurityconsumable test kitspen-side testinglivestock diagnosticsWSSV detectionEHP detection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Forte Biotech Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Forte Biotech Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantDec 8, 2023

Forte Biotech Investors

Notable investors and investment history

Forte Biotech Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Forte Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Forte Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersSingapore, Central Singapore
Employee Range17
Year Founded2021
Last FundingDec 8, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.